Cartesian Therapeutics
RNAC
#8358
Rank
A$0.29 B
Marketcap
A$11.47
Share price
-1.69%
Change (1 day)
-58.48%
Change (1 year)

Market capitalization of Cartesian Therapeutics (RNAC)

Market cap: A$0.29 Billion

As of March 2026 Cartesian Therapeutics has a market cap of A$0.29 Billion. This makes Cartesian Therapeutics the world's 8358th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Cartesian Therapeutics from 2016 to 2026

End of year Market Cap

Year Marketcap Change
2026A$0.29 B15%
2025A$0.25 B-67.93%
2024A$0.80 B393.5%
2023A$0.16 B-35.52%
2022A$0.25 B-54.29%
2021A$0.55 B30.53%
2020A$0.42 B45.12%
2019A$0.29 B245.84%
2018A$84.85 M-69.77%
2017A$0.28 B-35.15%
2016A$0.43 B

End of Day market cap according to different sources

On Mar 12th, 2026 the market cap of Cartesian Therapeutics was reported to be:

A$0.30 Billion
by Nasdaq info icon info icon
A$0.29 Billion
by CompaniesMarketCap info icon info icon